BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Rebelos E, Iozzo P, Guzzardi MA, Brunetto MR, Bonino F. Brain-gut-liver interactions across the spectrum of insulin resistance in metabolic fatty liver disease. World J Gastroenterol 2021; 27(30): 4999-5018 [PMID: 34497431 DOI: 10.3748/wjg.v27.i30.4999]
URL: https://www.wjgnet.com/1007-9327/full/v27/i30/4999.htm
Number Citing Articles
1
Vance L. Albaugh, Yanlin He, Heike Münzberg, Christopher D. Morrison, Sangho Yu, Hans-Rudolf Berthoud. Regulation of body weight: Lessons learned from bariatric surgeryMolecular Metabolism 2023; 68: 101517 doi: 10.1016/j.molmet.2022.101517
2
Júlia Pauli De Cól, Enzo Pereira de Lima, Fernanda Moris Pompeu, Adriano Cressoni Araújo, Ricardo de Alvares Goulart, Marcelo Dib Bechara, Lucas Fornari Laurindo, Nahum Méndez-Sánchez, Sandra Maria Barbalho. Underlying Mechanisms behind the Brain–Gut–Liver Axis and Metabolic-Associated Fatty Liver Disease (MAFLD): An UpdateInternational Journal of Molecular Sciences 2024; 25(7): 3694 doi: 10.3390/ijms25073694
3
Miikka-Juhani Honka, Eleni Rebelos, Simona Malaspina, Pirjo Nuutila. Hepatic Positron Emission Tomography: Applications in Metabolism, Haemodynamics and CancerMetabolites 2022; 12(4): 321 doi: 10.3390/metabo12040321
4
So Yeong Cheon, Juhyun Song. Novel insights into non-alcoholic fatty liver disease and dementia: insulin resistance, hyperammonemia, gut dysbiosis, vascular impairment, and inflammationCell & Bioscience 2022; 12(1) doi: 10.1186/s13578-022-00836-0
5
Taylor J. Kelty, Ryan J. Dashek, W. David Arnold, R. Scott Rector. Emerging Links between Nonalcoholic Fatty Liver Disease and NeurodegenerationSeminars in Liver Disease 2023; 43(01): 077 doi: 10.1055/s-0043-1762585
6
Amin Arif, Adil Farooq, Muddasir Hassan Abbasi, Muhammad Babar Khawar, Tasleem Akhtar, Humaira Allay Ali, Mehreen Anjum, Rabia Mehmood, Tayyaba Saleem, Nadeem Sheikh. Effect of heterologous platelet-rich plasma on liver and modulation of glucose metabolism and Wnt signalling pathways in diabetic miceMolecular Biology Reports 2023; 50(9): 7145 doi: 10.1007/s11033-023-08600-4
7
Johannes R. Hov, Tom H. Karlsen. The microbiota and the gut–liver axis in primary sclerosing cholangitisNature Reviews Gastroenterology & Hepatology 2023; 20(3): 135 doi: 10.1038/s41575-022-00690-y
8
Zhisheng Chen, Mengxin Chen, Ping Zeng, Xiaobo Yang, Qian Li. Association of aspirin with all-cause and cardiocerebrovascular mortality in patients with metabolic associated fatty liver diseaseScandinavian Journal of Gastroenterology 2023; 58(8): 908 doi: 10.1080/00365521.2023.2179864
9
Maurizia R. Brunetto, Antonio Salvati, Giovanni Petralli, Ferruccio Bonino. Nutritional intervention in the management of non-alcoholic fatty liver diseaseBest Practice & Research Clinical Gastroenterology 2023; : 101830 doi: 10.1016/j.bpg.2023.101830